64 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Greenland Technologies Holding Corporation GTEC shares climbed 180.3% to $6.56 after the company reported it will begin offering integrated electric drivetrain system to existing forklift OEM clientele to support manufacture of electric forklifts using lithium batteries.
• Summit Wireless Technologies, Inc. WISA gained 47.4% to $3.14 after the company reported 45% year-over-year revenue growth for the third quarter. The company also said it sees more than 100% year-over-year revenue growth for Q4.
• Trxade Group, Inc. MEDS shares gained 34.2% to $5.77 after the company entered into a solution marketing program agreement with Amazon.com Services, LLC to promote Amazon storage lockers.
• Preferred Apartment Communities, Inc. APTS surged 18.6% to $7.08 after the company reported Q3 results.
• Xperi Holding Corp XPER shares rose 18.3% to $16.48 after the company posted Q3 results.
• Infrastructure and Energy Alternatives, Inc. IEA gained 17.7% to $11.16 after the company reported better-than-expected Q3 results and raised FY20 sales guidance.
• OPKO Health, Inc. OPK gained 14.7% to $3.745, rebounding from Monday weakness.
• Altimmune, Inc. ALT rose 13.8% to $8.92 after reporting a narrower-than-expected quarterly loss.
• Western Midstream Partners LP WES rose 13.4% to $10.30 after the company reported better-than-expected Q3 results.
• StealthGas Inc. GASS gained 13.3% to $2.4250.
• Luna Innovations Incorporated LUNA surged 13.2% to $7.51 after reporting better-than-expected Q3 results.
• Sientra, Inc. SIEN gained 13.1% to $5.37 after reporting Q3 results. The company also appointed Ron Menezes as President and Chief Executive Officer.
• Harrow Health, Inc. HROW shares surged 11% to $5.65 after reporting Q3 results.
• Fulgent Genetics, Inc. FLGT climbed 10.8% to $34.37 after the company reported Q3 results.
• Western Midstream Partners, LP WES gained 10.8% to $10.14 following upbeat Q3 results.
• Humanigen, Inc. HGEN rose 9.8% to $88.75 after dipping 32% on Monday. Humanigen, on Friday, announced a Cooperative Research and Development Agreement with the DoD to develop lenzilumab for COVID-19. The company also announced "positive" data from its Phase 3 trial of lenzilumab.
• TimkenSteel Corporation TMST gained 9.8% to $4.72.
• Smart Sand, Inc. SND rose 9.7% to $1.58 after the company reported better-than-expected Q3 sales.
• Tidewater Inc. TDW gained 9.7% to $7.68. Tidewater released Q2 results last week.
• Inovio Pharmaceuticals, Inc. INO rose 9.5% to $9.30 after the company posted a profit for the third quarter.
• Quad/Graphics, Inc. QUAD gained 9.2% to $2.50. Quad/Graphics posted quarterly results last week.
• Stealth BioTherapeutics Corp MITO rose 8.7% to $1.38 after Morningside Venture Investments revealed a 72.3% active stake in the company.
• Vaxart, Inc. VXRT rose 7.6% to $3.7650 after declining 31% on Monday.
• Banco Santander, S.A. SAN rose 7.4% to $2.6850 after climbing around 17% on Monday.
• Harbor Custom Development, Inc. HCDI gained 7% to $5.26. Harbor Custom Development reported it has closed on Phase 3 sale of 66 Residential Lots at Soundview Estates in Bremerton, Washington for $7.788 million.
• Organogenesis Holdings Inc ORGO shares rose 6.8% to $4.43 following better-than-expected Q3 results.
• Ulta Beauty, Inc. ULTA gained 6.2% to $262.49 after the company and Target announced a strategic partnership.
• BP p.l.c. BP rose 6.1% to $19.18 after gaining over 15% on Monday.
• Affimed N.V. AFMD rose 5.5% to $3.9368 following Q3 results. Affimed and Roivant Sciences reported a licensing and strategic collaboration agreement.
• Arcturus Therapeutics Holdings Inc. ARCT rose 5.4% to $36.45 after the company posted downbeat quarterly results.
• Eli Lilly and Company LLY gained 4.4% to $148.53 as the company disclosed that its monoclonal antibody treatment bamlanivimab for use against COVID-19 received an emergency use authorization from the United States Food and Drug Administration.

Check out these big penny stock gainers and losers

Losers

• InnSuites Hospitality Trust IHT shares fell 33.8% to $1.9341 after surging around 82% on Monday.
• GasLog Partners LP GLOP shares dipped 31.7% to $2.35 after reporting downbeat Q3 results.
• Ashford Hospitality Trust, Inc. AHT fell 26.2% to $3.49.
• Arena Pharmaceuticals, Inc ARNA shares dropped 26% to $64.67 following a decline in Q3 sales.
• Kandi Technologies Group, Inc. KNDI fell 25% to $5.83 as the company announced entry into agreement for registered direct placement of $60 million of common stock and warrants.
• Jumia Technologies AG JMIA dropped 23.3% to $12.28 after reporting Q3 earnings.
• LiveRamp Holdings, Inc. RAMP fell 22.9% to $59.04 following Q2 results.
• Praxis Precision Medicines, Inc. PRAX fell 22.2% to $27.83 after the company issued a regulatory update on PRAX-114 program. Piper Sandler initiated coverage on Praxis Precision Medicine with an Overweight rating and announced a price target of $65.
• Aurora Cannabis Inc. ACB fell 21.8% to $8.77 after gaining over 14% on Monday.
• Medalist Diversified REIT, Inc. MDRR fell 21.3% to $2.0062.
• Beyond Meat, Inc. BYND shares dipped 21.1% to $118.75 after the company reported downbeat results for its third quarter. The company said it continues to experience meaningful slowdown in its Foodservice Unit.
• Voyager Therapeutics, Inc. VYGR dipped 21% to $8.84 after the company reported Q3 earnings results. Wells Fargo and Raymond James downloaded the stock.
• MediaAlpha, Inc. MAX fell 20% to $39.21.
• Yalla Group Limited YALA fell 19.1% to $9.32 following Q3 results.
• Sotherly Hotels Inc. SOHO dipped 19% to $2.0910 after surging 64% on Monday.
• Waitr Holdings Inc. WTRH shares declined 17.5% to $2.64 after reporting Q3 results.
• Applied UV, Inc. AUVI fell 17.4% to $5.28 as the company priced its 1.219 million share offering at $5.25 per share. Applied UV reported a non-binding letter to explore possibility of buying certain key assets of Akida, including rights to airocide system for airborne pathogen reduction for $12 million.
• Credicorp Ltd. BAP shares declined 16.5% to $114.81.
• Neurocrine Biosciences, Inc. NBIX fell 15.8% to $86.61 following weak quarterly sales.
• Exela Technologies, Inc XELA fell 14.1% to $0.3701 after the company reported Q3 results and issued weak sales forecast.
• GreenSky, Inc. GSKY dipped 13.8% to $3.74 following weak Q3 results.
• Vital Farms, Inc. VITL dropped 13.8% to $30.54 after the company reported Q3 results and announced a proposed secondary public offering of 5 million shares of common stock.
• Repay Holdings Corporation RPAY tumbled 13.6% to $22.90 following Q3 results.
• Nautilus, Inc. NLS fell 12.4% to $19.16 after the company reported Q3 results and also issued FY20 sales guidance. Nautilus also filed for mixed shelf offering of up to $100 million, according to SEC filing.
• Tilray, Inc. TLRY dipped 12.4% to $8.85 after the company reported worse-than-expected Q3 sales.
• Sundial Growers Inc. SNDL fell 11.8% to $0.4041 after jumping 83% on Monday. Sundial Growers is expected to report quarterly earnings on November 11. Sundial Growers highlighted expansion into edible market and will collaborate with Choklat.
• Tattooed Chef, Inc. TTCF dropped 11.8% to $17.70 after the company posted Q3 results.
• Novavax, Inc. NVAX fell 10% to $81.26 after reporting Q3 results.
• Carnival Corporation & Plc CUK fell 9.9% to $15.14 after jumping 41% on Monday.
• Ameri Holdings, Inc. AMRH fell 8.4% to $1.3466 after surging 14% on Monday.
• Akerna Corp. KERN fell 8.3% to $3.97 after gaining over 5% on Monday.
• TherapeuticsMD Inc TXMD fell 7.7% to $1.4025 after the company announced an underwritten public offering of its common stock.
• The RealReal, Inc. REAL shares fell 5.7% to $15.33 after reporting downbeat quarterly earnings.